![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC25A4 |
Gene summary for SLC25A4 |
![]() |
Gene information | Species | Human | Gene symbol | SLC25A4 | Gene ID | 291 |
Gene name | solute carrier family 25 member 4 | |
Gene Alias | AAC1 | |
Cytomap | 4q35.1 | |
Gene Type | protein-coding | GO ID | GO:0000002 | UniProtAcc | A0A0S2Z3H3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
291 | SLC25A4 | HTA11_347_2000001011 | Human | Colorectum | AD | 3.04e-12 | 3.77e-01 | -0.1954 |
291 | SLC25A4 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.16e-02 | 2.12e-01 | -0.059 |
291 | SLC25A4 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 5.27e-11 | 3.83e-01 | 0.294 |
291 | SLC25A4 | LZE4T | Human | Esophagus | ESCC | 1.03e-10 | 3.89e-01 | 0.0811 |
291 | SLC25A4 | LZE5T | Human | Esophagus | ESCC | 1.93e-06 | 2.91e-01 | 0.0514 |
291 | SLC25A4 | LZE7T | Human | Esophagus | ESCC | 8.49e-08 | 8.72e-01 | 0.0667 |
291 | SLC25A4 | LZE8T | Human | Esophagus | ESCC | 4.96e-08 | 2.37e-01 | 0.067 |
291 | SLC25A4 | LZE20T | Human | Esophagus | ESCC | 1.00e-02 | 3.15e-01 | 0.0662 |
291 | SLC25A4 | LZE22T | Human | Esophagus | ESCC | 4.55e-03 | 2.66e-01 | 0.068 |
291 | SLC25A4 | LZE24T | Human | Esophagus | ESCC | 2.29e-14 | 5.20e-01 | 0.0596 |
291 | SLC25A4 | LZE21T | Human | Esophagus | ESCC | 8.70e-05 | 2.38e-01 | 0.0655 |
291 | SLC25A4 | LZE6T | Human | Esophagus | ESCC | 1.94e-02 | 1.47e-01 | 0.0845 |
291 | SLC25A4 | P1T-E | Human | Esophagus | ESCC | 3.32e-08 | 3.30e-01 | 0.0875 |
291 | SLC25A4 | P2T-E | Human | Esophagus | ESCC | 8.57e-37 | 7.52e-01 | 0.1177 |
291 | SLC25A4 | P4T-E | Human | Esophagus | ESCC | 6.58e-34 | 9.10e-01 | 0.1323 |
291 | SLC25A4 | P5T-E | Human | Esophagus | ESCC | 3.58e-42 | 8.49e-01 | 0.1327 |
291 | SLC25A4 | P8T-E | Human | Esophagus | ESCC | 3.04e-37 | 6.67e-01 | 0.0889 |
291 | SLC25A4 | P9T-E | Human | Esophagus | ESCC | 6.04e-22 | 4.63e-01 | 0.1131 |
291 | SLC25A4 | P10T-E | Human | Esophagus | ESCC | 5.83e-40 | 7.17e-01 | 0.116 |
291 | SLC25A4 | P11T-E | Human | Esophagus | ESCC | 3.78e-12 | 5.03e-01 | 0.1426 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19031469 | Oral cavity | OSCC | regulation of autophagy of mitochondrion | 25/7305 | 33/18723 | 1.95e-05 | 1.87e-04 | 25 |
GO:00162393 | Oral cavity | OSCC | positive regulation of macroautophagy | 40/7305 | 63/18723 | 7.19e-05 | 5.67e-04 | 40 |
GO:199054218 | Oral cavity | OSCC | mitochondrial transmembrane transport | 56/7305 | 102/18723 | 8.06e-04 | 4.32e-03 | 56 |
GO:00004238 | Oral cavity | OSCC | mitophagy | 19/7305 | 28/18723 | 1.88e-03 | 8.84e-03 | 19 |
GO:00442826 | Oral cavity | OSCC | small molecule catabolic process | 174/7305 | 376/18723 | 2.25e-03 | 1.00e-02 | 174 |
GO:19012642 | Oral cavity | OSCC | carbohydrate derivative transport | 44/7305 | 80/18723 | 2.67e-03 | 1.16e-02 | 44 |
GO:0097300 | Oral cavity | OSCC | programmed necrotic cell death | 28/7305 | 47/18723 | 3.41e-03 | 1.45e-02 | 28 |
GO:01061065 | Oral cavity | OSCC | cold-induced thermogenesis | 71/7305 | 144/18723 | 7.51e-03 | 2.75e-02 | 71 |
GO:01201615 | Oral cavity | OSCC | regulation of cold-induced thermogenesis | 71/7305 | 144/18723 | 7.51e-03 | 2.75e-02 | 71 |
GO:00016594 | Oral cavity | OSCC | temperature homeostasis | 84/7305 | 174/18723 | 7.84e-03 | 2.87e-02 | 84 |
GO:00702653 | Oral cavity | OSCC | necrotic cell death | 34/7305 | 62/18723 | 8.23e-03 | 3.00e-02 | 34 |
GO:006156410 | Oral cavity | OSCC | axon development | 207/7305 | 467/18723 | 1.01e-02 | 3.51e-02 | 207 |
GO:19908454 | Oral cavity | OSCC | adaptive thermogenesis | 76/7305 | 157/18723 | 1.02e-02 | 3.52e-02 | 76 |
GO:19035998 | Oral cavity | OSCC | positive regulation of autophagy of mitochondrion | 9/7305 | 12/18723 | 1.27e-02 | 4.24e-02 | 9 |
GO:00002661 | Oral cavity | OSCC | mitochondrial fission | 24/7305 | 42/18723 | 1.30e-02 | 4.34e-02 | 24 |
GO:004828511 | Oral cavity | LP | organelle fission | 145/4623 | 488/18723 | 6.02e-03 | 3.57e-02 | 145 |
GO:000989625 | Oral cavity | EOLP | positive regulation of catabolic process | 118/2218 | 492/18723 | 2.32e-14 | 9.26e-12 | 118 |
GO:003133125 | Oral cavity | EOLP | positive regulation of cellular catabolic process | 106/2218 | 427/18723 | 4.63e-14 | 1.63e-11 | 106 |
GO:001593121 | Oral cavity | EOLP | nucleobase-containing compound transport | 58/2218 | 222/18723 | 3.44e-09 | 2.10e-07 | 58 |
GO:001050622 | Oral cavity | EOLP | regulation of autophagy | 74/2218 | 317/18723 | 5.84e-09 | 3.07e-07 | 74 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05012 | Colorectum | AD | Parkinson disease | 147/2092 | 266/8465 | 2.53e-27 | 8.48e-25 | 5.41e-25 | 147 |
hsa05208 | Colorectum | AD | Chemical carcinogenesis - reactive oxygen species | 126/2092 | 223/8465 | 1.01e-24 | 1.68e-22 | 1.07e-22 | 126 |
hsa05415 | Colorectum | AD | Diabetic cardiomyopathy | 114/2092 | 203/8465 | 3.65e-22 | 3.06e-20 | 1.95e-20 | 114 |
hsa05010 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa05016 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa05020 | Colorectum | AD | Prion disease | 133/2092 | 273/8465 | 2.47e-18 | 8.29e-17 | 5.29e-17 | 133 |
hsa05022 | Colorectum | AD | Pathways of neurodegeneration - multiple diseases | 201/2092 | 476/8465 | 4.54e-18 | 1.27e-16 | 8.09e-17 | 201 |
hsa05017 | Colorectum | AD | Spinocerebellar ataxia | 60/2092 | 143/8465 | 3.78e-06 | 4.35e-05 | 2.78e-05 | 60 |
hsa05166 | Colorectum | AD | Human T-cell leukemia virus 1 infection | 72/2092 | 222/8465 | 5.24e-03 | 2.44e-02 | 1.55e-02 | 72 |
hsa04218 | Colorectum | AD | Cellular senescence | 53/2092 | 156/8465 | 5.55e-03 | 2.48e-02 | 1.58e-02 | 53 |
hsa050121 | Colorectum | AD | Parkinson disease | 147/2092 | 266/8465 | 2.53e-27 | 8.48e-25 | 5.41e-25 | 147 |
hsa052081 | Colorectum | AD | Chemical carcinogenesis - reactive oxygen species | 126/2092 | 223/8465 | 1.01e-24 | 1.68e-22 | 1.07e-22 | 126 |
hsa054151 | Colorectum | AD | Diabetic cardiomyopathy | 114/2092 | 203/8465 | 3.65e-22 | 3.06e-20 | 1.95e-20 | 114 |
hsa050101 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa050161 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa050201 | Colorectum | AD | Prion disease | 133/2092 | 273/8465 | 2.47e-18 | 8.29e-17 | 5.29e-17 | 133 |
hsa050221 | Colorectum | AD | Pathways of neurodegeneration - multiple diseases | 201/2092 | 476/8465 | 4.54e-18 | 1.27e-16 | 8.09e-17 | 201 |
hsa050171 | Colorectum | AD | Spinocerebellar ataxia | 60/2092 | 143/8465 | 3.78e-06 | 4.35e-05 | 2.78e-05 | 60 |
hsa051661 | Colorectum | AD | Human T-cell leukemia virus 1 infection | 72/2092 | 222/8465 | 5.24e-03 | 2.44e-02 | 1.55e-02 | 72 |
hsa042181 | Colorectum | AD | Cellular senescence | 53/2092 | 156/8465 | 5.55e-03 | 2.48e-02 | 1.58e-02 | 53 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC25A4 | SNV | Missense_Mutation | novel | c.367N>A | p.Ala123Thr | p.A123T | P12235 | protein_coding | tolerated(0.06) | possibly_damaging(0.801) | TCGA-A2-A4S1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC25A4 | SNV | Missense_Mutation | c.238N>T | p.Arg80Cys | p.R80C | P12235 | protein_coding | deleterious(0.01) | possibly_damaging(0.645) | TCGA-A8-A08R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SLC25A4 | SNV | Missense_Mutation | c.166N>C | p.Asp56His | p.D56H | P12235 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SLC25A4 | SNV | Missense_Mutation | novel | c.657N>G | p.Ser219Arg | p.S219R | P12235 | protein_coding | tolerated(0.13) | benign(0.109) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
SLC25A4 | SNV | Missense_Mutation | c.344N>A | p.Gly115Asp | p.G115D | P12235 | protein_coding | deleterious(0.01) | probably_damaging(0.982) | TCGA-AD-6888-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
SLC25A4 | SNV | Missense_Mutation | c.455N>A | p.Arg152His | p.R152H | P12235 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD | |
SLC25A4 | SNV | Missense_Mutation | rs748031233 | c.670N>A | p.Ala224Thr | p.A224T | P12235 | protein_coding | deleterious(0) | possibly_damaging(0.869) | TCGA-AZ-4313-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC25A4 | SNV | Missense_Mutation | c.740N>T | p.Ala247Val | p.A247V | P12235 | protein_coding | deleterious(0.04) | benign(0.013) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SLC25A4 | SNV | Missense_Mutation | c.848G>A | p.Gly283Asp | p.G283D | P12235 | protein_coding | deleterious(0.02) | possibly_damaging(0.899) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SLC25A4 | SNV | Missense_Mutation | novel | c.703C>T | p.Arg235Cys | p.R235C | P12235 | protein_coding | tolerated(0.06) | possibly_damaging(0.554) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
291 | SLC25A4 | DRUGGABLE GENOME, TRANSPORTER | Clodronate | CLODRONIC ACID | ||
291 | SLC25A4 | DRUGGABLE GENOME, TRANSPORTER | inhibitor | 178101293 | ||
291 | SLC25A4 | DRUGGABLE GENOME, TRANSPORTER | CLODRONATE | CLODRONIC ACID | ||
291 | SLC25A4 | DRUGGABLE GENOME, TRANSPORTER | inhibitor | 53801038 |
Page: 1 |